Treatment of Discogenic Back Pain — EGID  

Discogenic Back Pain Clinical Trial

Official title: Intradiscal Injection of Gelified Ethanol for the Treatment of Discogenic Back Pain

Status Terminated

Clinical Trial Summary

Discogenic low back pain is the most common form of chronic low back pain. Its diagnosis is mainly based on MR imaging, showing MODIC I or II changes in patients with concordant symptomatology. The treatment of discogenic low back pain is nevertheless difficult: intradiscal therapies (corticosteroids, methylene blue, radiofrequency) have a limited efficacy, and surgical procedures (arthrodesis or disc replacement) are a final recourse with notable risk of side-effects.

In this study, the efficacy of intradiscal injection of gelified ethanol (DiscoGel) in patients with disabling discogenic pain is assessed.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Back Pain
• Discogenic Back Pain

• NCT number: NCT02089139
• Study type: Interventional
• Source: University Hospital, Limoges
• Status: Terminated
• Phase: N/A
• Start date: May 2014
• Completion date: September 2018